Mirae Asset Global Etfs Holdings Ltd. Immuneering Corp Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Immuneering Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 11,389 shares of IMRX stock, worth $25,966. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,389Holding current value
$25,966% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMRX
# of Institutions
60Shares Held
9.65MCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.88MShares$4.29 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.07MShares$2.44 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny953KShares$2.17 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD859KShares$1.96 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY742KShares$1.69 Million0.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $60.2M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...